ácidos grasos - Campus Virtual de Salud Pública - Nodo Costa Rica

92
2006
San José
Costa Rica
Rafael Monge-Rojas, PhD. INCIENSA
Hannia Campos Nuñez, PhD. Escuela de Salud Pública, Universidad de Harvard
43. Hu FB, Stampfer MJ, Manson JE, et al.Dietary intake of alpha-linolenic acid and risks
of ischemic heart disease among women. Am J Clin Nutr. 1999; 827-8
44. Baylin A, Kabagambe E, Ascherio A, Spiegelman D, Campos H. Adipose tissue αlinolenic
acid and nonfatal acute myocardial infarction in Costa Rica. Circulation;
2003: 107: 1586-91.
45. Djoussé L, Pankow JS, Eckfeldt JH, et al. Relationship between dietary linolenic acid
and coronary artery disease in the National Heart, Lung, and Blood Institute Family
Heart Study. Am J Clin Nutr. 2004; 14: 612-19.
46. Guallar E, Aro A, Jiménez J, et al. Omega 3 fatty acids in adipose tissue and risks of
myocardial infarction. The EUREMIC Study. Arteroscler Thromb Vasc Biol. 1999;
19:1111-18.
47. Oomen CM, Ocke MC, Feskens EJ, et al. α -Linolenic acid intake in not beneficially
associated with 10 – y risks of coronary artery disease incidence: The Zutphen Elderly
Study. Am J Clin Nutr. 2001; 74: 757-63.
48. Pedersen JI, Ringstand J, Almendingen K, et al. Adipose tissue fatty acid and risks of
myocardial infarction: a case – control study. Eur J Clin Nutr. 2000; 54: 618-25.
49. Mozaffarian D, Ascherio A, Hu F, et al. Interplay between different polyunsaturated
fatty acids and risk of coronary heart disease in men. Circulation.2005; 111: 167-64.
50. Connor W. α -Linolenic acid in heath and disease. Am J Clin Nutr. 1999; 69:827-8.
51. Griffin B. The effect of n-3 fatty acids on low density lipoproteins subs fractions.
Lipids. 2001; 36: 915-75.
52. Lobby P, Ridker P, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;
105: 1115-43.
53. De Caterina R, Zampolli A. n-3 Fatty Acids: Antiatherosclerotic effects. Lipids. 2001;
36: 695-785.
54. Albert C, Campos H, Stampfer J. Blood Levels of long – chain n-3 fatty acids and the
TABLA DE COMPOSICIÓN DE ALIMENTOS DE COSTA RICA
Á C I D O S G R A S O S
risks of sudden death. N Engl J Med. 2002; 345: 1113-8.
55. Jouven X, Charles MA, Desnos M, Ducimetiere P. Circulating nonesterified fatty level
as a predictive risks factor for sudden death in the population. Circulation. 2001; 104:
756-71.
56. Ascherio A, Katan M, Zock P., Stampfer M, Willet W. Trans fatty acids and coronary
heart disease. N Engl. J Med. 1999; 340: 1994-98.
57. Lichtenstein A. Dietary trans fatty acids. J Cardiopulmonary Rehabil. 2000; 20: 143-
6.
58. Stampfer MJ, Sacks FM, Salvini S, Willet W, Hennekens CH. A prospective study
of cholesterol, apolipoproteins, and the risks of myocardial infarction. N Eng. J Med.
1991; 325: 373-81.
59. Oomen C, Ocke MC, Feskens JM, van Erp-Barst MJ, Kok FJ, Kromhout D. Association
between trans fatty acids and 10- year risks of coronary heart disease in the Zutphen
Elderly Study: a prospective population based study. Lancet. 2001; 357: 746-51.
60. Aro A, Kardinaal A, Salminen I, et al. Adipose tissue isomeric trans fatty acids and
risks of myocardial infarction in nine countries: The EUREMIC study. Lancet. 1995:
345: 273-78.
61. Pedersen J, Ringstand J, Almendingen K, Haúgen T, Stensvold I, Thelle DS. Adipose
tissue fatty acids and risks of myocardial infarction: a case- control study. Eur J Clin
Nutr. 2000; 54: 618-25.
62. Lemaitre R, King I, Raghunathan T, et al. Cell membrane trans-fatty acids and the risks
of primary cardiac arrest. Circulation. 2002; 105: 697-701.
63. Dlohy P, Trzicka E, Stankova B. et al. Higher concentration of 18:1 trans-fatty acids in
subcutaneous fat of persons with coronary graphically documented atherosclerosis of
the coronary arteries. Ann Nut Metab. 2003; 47: 302-5.
64. Baylin A, Kabagambe E, Ascherio A, Spiegelman D, Campos H. High 18:2 trans-fatty
acids in adipose tissue are associated with increased risks of nonfatal acute myocardial
infarction in Costa Rica adults. J Nutr. 2003; 133: 1186-91.